Cearvol Diamond X1 vs Otofonix Groove

The Cearvol Diamond X1 is a budget-priced OTC hearing aid available for $199, earning a B grade with a SoundScore of 3.7/5 in our lab testing. This visible-in-ear style device ranks #30 among 65 OTC hearing aids tested, placing it in the top 45% of its category. The Diamond X1 delivers a mixed performance profile with one notable strength: music streaming. With a score of 4.1/5, it performs 2.18 points above the category average—a substantial margin that makes it appealing for users who value audio entertainment through their hearing aids. Feedback handling is excellent at 4.5/5, providing stable performance during typical daily movements. Both iPhone and Android streaming are supported with rechargeable batteries for convenience. Speech performance presents a more modest picture. Speech in quiet scores 2.8/5, which is above the category average but only mixed in absolute terms. Speech in noise measures 1.7/5—above the category average of 1.48/5, though still low overall. Own-voice comfort is a weakness at 1.7/5, falling 0.81 points below the category average, which may cause your own voice to sound unnatural or boomy. The Diamond X1 is best suited for budget-conscious consumers who prioritize music and media streaming over maximum speech clarity. Those seeking stronger speech performance in challenging listening environments may want to consider higher-scoring alternatives in this price range, such as the Elehear Beyond or Apple AirPods Pro 2.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.